Hudson Executive Capital LP Akoya Biosciences, Inc. Transaction History

Hudson Executive Capital LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$7.6 - $12.68 $3.64 Million - $6.07 Million	-478,491 Reduced 21.61%	1,736,017 $14.2 Million
Q4 2022 Feb 14, 2023	SELL	$8.6 - $14.1 $12.8 Million - $20.9 Million	-1,483,050 Reduced 40.11%	2,214,508 $21.2 Million
Q3 2022 Nov 14, 2022	BUY	$10.63 - $15.76 $13.3 Million - $19.7 Million	1,250,000 Added 51.07%	3,697,558 $43.4 Million
Q1 2022 May 16, 2022	BUY	$9.84 - $14.97 $445,801 - $678,215	45,305 Added 1.89%	2,447,558 $26.9 Million
Q4 2021 Feb 14, 2022	BUY	$11.37 - $15.31 $6.28 Million - $8.46 Million	552,410 Added 29.86%	2,402,253 $36.8 Million
Q3 2021 Nov 15, 2021	BUY	$13.04 - $21.0 $10.2 Million - $16.4 Million	779,859 Added 72.89%	1,849,843 $25.8 Million
Q2 2021 Aug 16, 2021	BUY	$17.89 - $26.05 $19.1 Million - $27.9 Million	1,069,984 New	1,069,984 $20.7 Million

12.3M

24.1K

Ticker AKYA
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 37,892,300
Market Cap $96.2M
Description
Akoya Biosciences, Inc., a life sciences technology company, provides spatial biology solutions focused on transforming discovery and clinical research in North America, the Asia Pacific, Europe, the Middle East, and Africa. The company offers PhenoCycler instrument, a compact bench-top fluidics system that integrates with a companion microscope...

Get notified when there are updates to the investment portfolio of Hudson Executive Capital LP, based on Form 13F filings with the SEC.

Stay updated on Hudson Executive Capital LP with notifications on news.